LEON FRANCISCO (Chief Scientific Officer) sold 10.6% of their position (187K shares) of PROVENTION BIO, INC. on the open market
Open‑market sale worth $1.92M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/30/2022ACC: 0001493152-22-037133
DirectorOfficer10% Owner· Chief Scientific Officer
Since Jul 2018
-187K
Net shares
Net seller
$1.92M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
187K acquired · 374K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+187K
Price / share
$2.50
Trade value
$467.50K
% of position
11.9%
12/29/2022
1.57M→1.76M
Common Stock
Direct
Shares
−187K
Price / share
$10.26
Trade value
$1.92M
% of position
10.6%
12/29/2022
1.76M→1.57M
Total
Net shares
+0.00
Net value
-$1.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/29/2022 | M · Option Exercise | +187K | $2.50 | $467.50K | 11.9% | 1.57M | 1.76M |
| Common Stock Direct | 12/29/2022 | S · Sale | −187K | $10.26 | $1.92M | 10.6% | 1.76M | 1.57M |
| Total | +0.00 | -$1.45M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
187K shares
Shares
−187K
Strike price
2.5
Held after
342.10K
Exercisable
—
12/29/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock187K shares | 12/29/2022 | M · Option Exercise | −187K | 2.5 | — | 342.10K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1M
Total
1M indirect1M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1M | Indirect |
| Total | 1M | 1M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported